Published in Arch Dis Child on February 04, 2009
Genome-wide homozygosity analysis reveals HADH mutations as a common cause of diazoxide-responsive hyperinsulinemic-hypoglycemia in consanguineous pedigrees. J Clin Endocrinol Metab (2011) 1.87
ABCC8 R1420H Loss-of-Function Variant in a Southwest American Indian Community: Association With Increased Birth Weight and Doubled Risk of Type 2 Diabetes. Diabetes (2015) 1.45
Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations. Eur J Endocrinol (2010) 1.39
Multidomain integration in the structure of the HNF-4α nuclear receptor complex. Nature (2013) 1.30
Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. Eur J Endocrinol (2013) 1.26
Hypoglycaemia following diabetes remission in patients with 6q24 methylation defects: expanding the clinical phenotype. Diabetologia (2012) 1.04
Hyperinsulinemic Hypoglycemia - The Molecular Mechanisms. Front Endocrinol (Lausanne) (2016) 0.91
Clinical and molecular characterisation of hyperinsulinaemic hypoglycaemia in infants born small-for-gestational age. Arch Dis Child Fetal Neonatal Ed (2013) 0.89
The Diagnosis and Management of Hyperinsulinaemic Hypoglycaemia. J Clin Res Pediatr Endocrinol (2015) 0.83
Clinical and molecular data from 61 Brazilian cases of Congenital Hyperinsulinemic Hypoglycemia. Diabetol Metab Syndr (2015) 0.81
A combination of nifedipine and octreotide treatment in an hyperinsulinemic hypoglycemic infant. J Clin Res Pediatr Endocrinol (2014) 0.80
Current understanding of K ATP channels in neonatal diseases: focus on insulin secretion disorders. Acta Pharmacol Sin (2011) 0.77
Drug-induced hepatitis following use of octreotide for long-term treatment of congenital hyperinsulinism. BMJ Case Rep (2012) 0.76
Congenital hyperinsulinism: Role of fluorine-18L-3, 4 hydroxyphenylalanine positron emission tomography scanning. World J Radiol (2014) 0.75
Hyperinsulinemic hypoglycemia: clinical, molecular and therapeutical novelties. J Inherit Metab Dis (2017) 0.75
Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia (2010) 4.13
A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene. Nat Genet (2000) 2.87
Hemangiomas, vascular malformations, and lymphovenous malformations: classification and methods of treatment. Plast Reconstr Surg (1993) 2.80
Practical management of hyperinsulinism in infancy. Arch Dis Child Fetal Neonatal Ed (2000) 2.70
Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis. Curr Biol (1999) 2.65
Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet (1998) 2.53
Adjusting for patient characteristics when analyzing reports from patients about hospital care. Med Care (2001) 2.46
Mutations in the human delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis. Nat Genet (2000) 2.28
Usefulness of cardiac troponin I in patients undergoing open heart surgery. Am Heart J (2001) 2.26
An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med J Aust (1996) 2.25
Mutations in hepatocyte nuclear factor-1beta and their related phenotypes. J Med Genet (2005) 2.24
Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia (2006) 2.24
Widespread dissemination of metal debris from implants. J Bone Joint Surg Br (1994) 2.19
Penetration of the skull base by dissecting keratocyst. J Craniomaxillofac Surg (1993) 2.16
General practitioners' confidence in diagnosing and managing eye conditions: a survey in south Devon. Br J Gen Pract (1992) 2.16
Improved genetic testing for monogenic diabetes using targeted next-generation sequencing. Diabetologia (2013) 2.13
Haemangioma of the body of the mandible: a case report. Br J Oral Maxillofac Surg (2003) 2.05
Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest (2001) 2.01
A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum Mol Genet (2001) 1.98
Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes (1999) 1.97
The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia (2012) 1.89
A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain. Neurology (2007) 1.89
Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1 beta. Kidney Int (2000) 1.87
A distant 10-bp sequence specifies the boundaries of a programmed DNA deletion in Tetrahymena. Genes Dev (1993) 1.84
Patterns of recreational drug use at dance events in Edinburgh, Scotland. Addiction (2001) 1.79
Impaired fatty acid oxidation in propofol infusion syndrome. Lancet (2001) 1.75
Epidemiological perspectives on Hendra virus infection in horses and flying foxes. Aust Vet J (2007) 1.73
Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births. Diabetologia (2009) 1.70
Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease. Am J Hum Genet (2000) 1.64
Insulin dependent diabetes in children under 5: incidence and ascertainment validation for 1992. BMJ (1995) 1.63
Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J Clin Invest (1999) 1.60
Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection. Diabetologia (2005) 1.60
The laminopathies: a clinical review. Clin Genet (2006) 1.59
Proposal for a standardized protocol for 18F-DOPA-PET (PET/CT) in congenital hyperinsulinism. Horm Res (2006) 1.58
A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients. Diabet Med (2009) 1.54
SLC2A2 mutations can cause neonatal diabetes, suggesting GLUT2 may have a role in human insulin secretion. Diabetologia (2012) 1.54
A fatal case of Hendra virus infection in a horse in north Queensland: clinical and epidemiological features. Aust Vet J (2000) 1.54
Prolonged ambulatory colonic manometric studies using endoclips. Gastrointest Endosc (2000) 1.52
Biological and morphological aspects of the growth of equine abortion virus. J Bacteriol (1966) 1.49
Clinical presentation of 6q24 transient neonatal diabetes mellitus (6q24 TNDM) and genotype-phenotype correlation in an international cohort of patients. Diabetologia (2013) 1.48
Amplification of PCR products in excess of 600 base pairs using DNA extracted from decalcified, paraffin wax embedded bone marrow trephine biopsies. Mol Pathol (2000) 1.48
beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes (2001) 1.47
Summertime actinic lichenoid eruption, a distinct entity, should be termed actinic lichen nitidus. Arch Dermatol (1998) 1.47
Prevalence of acute conjunctivitis caused by chlamydia, adenovirus, and herpes simplex virus in an ophthalmic casualty department. Br J Ophthalmol (1984) 1.44
The evolving course of HNF4A hyperinsulinaemic hypoglycaemia--a case series. Diabet Med (2014) 1.42
p57(KIP2) expression in normal islet cells and in hyperinsulinism of infancy. Diabetes (2001) 1.42
Speech perception in noise with implant and hearing aid. Am J Otol (1997) 1.41
Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations. Eur J Endocrinol (2010) 1.39
Hepatocyte nuclear factor-1beta: a new kindred with renal cysts and diabetes and gene expression in normal human development. J Am Soc Nephrol (2001) 1.36
Immunological cross-reactivity of enterotoxins of Aeromonas hydrophila and cholera toxin. Clin Exp Immunol (1982) 1.33
Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21. Hum Mol Genet (1997) 1.32
Mutation of the LUNATIC FRINGE gene in humans causes spondylocostal dysostosis with a severe vertebral phenotype. Am J Hum Genet (2005) 1.31
Melioidosis in intensive piggeries in south eastern Queensland. Aust Vet J (1986) 1.31
Mutations in the hepatocyte nuclear factor-1alpha gene are a common cause of maturity-onset diabetes of the young in the U.K. Diabetes (1997) 1.29
Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation. Diabet Med (2008) 1.29
A comparison of the susceptibility to praziquantel of Schistosoma haematobium, S. japonicum, S. mansoni, S. intercalatum and S. mattheei im hamsters. Z Parasitenkd (1977) 1.29
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue. J Infect Dis (1995) 1.28
Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet (2001) 1.26
Different origin of auditory and phonological processing problems in children with language impairment: evidence from a twin study. J Speech Lang Hear Res (1999) 1.25
beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations. Diabetes (2001) 1.25
A phase II study of ifosfamide in children with recurrent solid tumours. Cancer Chemother Pharmacol (1985) 1.24
Distribution analysis of vitamin D highlights differences in population subgroups: preliminary observations from a pilot study in UK adults. J Endocrinol (2003) 1.23
Entities and frequency of neonatal diabetes: data from the diabetes documentation and quality management system (DPV). Diabet Med (2010) 1.20
Pregnancy outcome in patients with raised blood glucose due to a heterozygous glucokinase gene mutation. Diabet Med (2009) 1.20
Novel mutations in DLL3, a somitogenesis gene encoding a ligand for the Notch signalling pathway, cause a consistent pattern of abnormal vertebral segmentation in spondylocostal dysostosis. J Med Genet (2003) 1.19
Marrow suppression and intravenous cimetidine. Lancet (1978) 1.19
The genetic basis of congenital hyperinsulinism. J Med Genet (2009) 1.19
Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1beta in human pancreatic development. Diabet Med (2006) 1.18
Role of fine needle aspiration cytology in the management of the discrete parotid lump. Ann R Coll Surg Engl (1997) 1.17
The mutated human gene encoding hepatocyte nuclear factor 1beta inhibits kidney formation in developing Xenopus embryos. Proc Natl Acad Sci U S A (2000) 1.16
Predictive genetic testing in maturity-onset diabetes of the young (MODY). Diabet Med (2001) 1.13
Survival outcome and cost-effectiveness with docetaxel and paclitaxel in patients with metastatic breast cancer: a population-based evaluation. Ann Oncol (2007) 1.12
Confirmation of linkage of Duane's syndrome and refinement of the disease locus to an 8.8-cM interval on chromosome 2q31. Hum Genet (2000) 1.11
JAG1 mutations are found in approximately one third of patients presenting with only one or two clinical features of Alagille syndrome. Clin Genet (2011) 1.11
Complementary studies of the gastrointestinal safety of the cyclo-oxygenase-2-selective inhibitor etoricoxib. Aliment Pharmacol Ther (2003) 1.11
Blood transfusion and chronic lung disease in preterm infants. Eur J Pediatr (1997) 1.10
Betulinic acid derivatives: a new class of human immunodeficiency virus type 1 specific inhibitors with a new mode of action. J Med Chem (1996) 1.10
Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis. Clin Exp Immunol (2009) 1.09
Heterozygous ABCC8 mutations are a cause of MODY. Diabetologia (2011) 1.09
Novel GLIS3 mutations demonstrate an extended multisystem phenotype. Eur J Endocrinol (2010) 1.08
Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis. Leukemia (2006) 1.07
Human Bak induces cell death in Schizosaccharomyces pombe with morphological changes similar to those with apoptosis in mammalian cells. Mol Cell Biol (1997) 1.07
Measurement of the neutrino mass splitting and flavor mixing by MINOS. Phys Rev Lett (2011) 1.07
First direct observation of muon antineutrino disappearance. Phys Rev Lett (2011) 1.07
The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism. Eur J Endocrinol (2011) 1.06
Histological features of acute hepatitis after imatinib mesylate treatment. Leukemia (2003) 1.06
CLearance of calcium pyrophosphate dihydrate crystals in vivo. II. Studies using triclinic crystals doubly labeled with 45Ca and 85Sr. Arthritis Rheum (1979) 1.05
Formic acid decalcification of bone marrow trephines degrades DNA: alternative use of EDTA allows the amplification and sequencing of relatively long PCR products. Mol Pathol (2000) 1.04
Practice patterns for antibiotic de-escalation in culture-negative healthcare-associated pneumonia. Infection (2010) 1.04